Bouvier D, Cantais A, Laspougeas A, Lorton F, Plenier Y, Cottier M, Fournier P, Tran A, Moreau E, Durif J, Sarret C, Mourgues C, Sturtz F, Oudart JB, Raffort J, Gonzalo P, Cristol JP, Masson D, Pereira B, Sapin V

JAMA Netw Open. 2024 03 4;7(3):e242366

Prospective 25-year surveillance of prion diseases in France, 1992 to 2016: a slow waning of epidemics and an increase in observed sporadic forms.

Denouel A, Brandel JP, Peckeu-Abboud L, Seilhean D, Bouaziz-Amar E, Quadrio I, Oudart JB, Lehmann S, Bellecave P, Laplanche JL, Haik S

Euro Surveill. 2023 12;28(50):

Mutational Characteristics of Primary Mucosal Melanoma: A Systematic Review.

Beaudoux O, Oudart JB, Riffaud L, Visseaux L, Marchal A, Lebre AS, Grange F

Mol Diagn Ther. 2022 Feb 23;:

Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview.

Delaby C, Teunissen CE, Blennow K, Alcolea D, Arisi I, Amar EB, Beaume A, Bedel A, Bellomo G, Bigot-Corbel E, Bjerke M, Blanc-Quintin MC, Boada M, Bousiges O, Chapman MD, DeMarco ML, D'Onofrio M, Dumurgier J, Dufour-Rainfray D, Engelborghs S, Esselmann H, Fogli A, Gabelle A, Galloni E, Gondolf C, Grandhomme F, Grau-Rivera O, Hart M, Ikeuchi T, Jeromin A, Kasuga K, Keshavan A, Khalil M, Körtvelyessy P, Kulczynska-Przybik A, Laplanche JL, Lewczuk P, Li QX, Lleó A, Malaplate C, Marquié M, Masters CL, Mroczko B, Nogueira L, Orellana A, Otto M, Oudart JB, Paquet C, Paoletti FP, Parnetti L, Perret-Liaudet A, Peoc'h K, Poesen K, Puig-Pijoan A, Quadrio I, Quillard-Muraine M, Rucheton B, Schraen S, Schott JM, Shaw LM, Suárez-Calvet M, Tsolaki M, Tumani H, Udeh-Momoh CT, Vaudran L, Verbeek MM, Verde F, Vermunt L, Vogelgsang J, Wiltfang J, Zetterberg H, Lehmann S

Alzheimers Dement. 2021 Dec 22;:

F4, a collagen XIX-derived peptide, inhibits tumor angiogenesis through αvβ3 and α5β1 integrin interaction.

Oudart JB, Villemin M, Brassart B, Sellier C, Terryn C, Dupont-Deshorgue A, Monboisse JC, Maquart FX, Ramont L, Brassart-Pasco S

Cell Adh Migr. 2021 Dec;15(1):215-223

Clinical assessment of the miR-34, miR-200, ZEB1 and SNAIL EMT regulation hub underlines the differential prognostic value of EMT miRs to drive mesenchymal transition and prognosis in resected NSCLC.

Garinet S, Didelot A, Denize T, Perrier A, Beinse G, Leclere JB, Oudart JB, Gibault L, Badoual C, Le Pimpec-Barthes F, Laurent-Puig P, Legras A, Blons H

Br J Cancer. 2021 Oct 12;:

Response to Imatinib in a Patient with Double-mutant KIT Metastatic Penile Melanoma.

Beaudoux O, Ehret M, Criquet E, Franceschi J, Durlach A, Oudart JB, Visseaux L, Grange F

Acta Derm Venereol. 2020 Dec 7;:

PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project.

Blons H, Oudart JB, Merlio JP, Debieuvre D, de Fraipont F, Audigier-Valette C, Escande F, Hominal S, Bringuier PP, Fraboulet-Moreau S, Ouafik L, Moro-Sibilot D, Lemoine A, Langlais A, Missy P, Morin F, Souquet PJ, Barlesi F, Cadranel J, Beau-Faller M,

Lung Cancer. 2020 Nov 13;:

A Mysteriously Low Creatinine Concentration.

Chabert A, Simon A, Gitton A, Schneider N, Oudart JB

. 2020 Oct 1;66(10):1358-1359

Clinical and biological features of haptoglobin phenotypes.

Simon A, Schneider N, Gillery P, Oudart JB

Ann Biol Clin (Paris). 2020 Oct 1;78(5):493-498

Immunotherapy in non-small-cell lung cancer: from targeted molecules to resistance patterns.

Brassart-Pasco S, Dalstein V, Brassart B, Dewolf M, Clavel C, Oudart JB

Pharmacogenomics. 2020 Jun 22;:

Lactic Acidosis after Drinking Mysterious Beverage.

Thomson G, Simon A, Cazaubon Y, Schneider N, Oudart JB

Clin. Chem.. 2020 May 1;66(5):744-745

Angiogenesis Inhibition by a Short 13 Amino Acid Peptide Sequence of Tetrastatin, the α4(IV) NC1 Domain of Collagen IV.

Vautrin-Glabik A, Devy J, Bour C, Baud S, Choulier L, Hoarau A, Dupont-Deshorgue A, Sellier C, Brassart B, Oudart JB, Ramont L, Monboisse JC, Brassart-Pasco S

Front Cell Dev Biol. 2020 ;8:775

Extracellular Vesicle-Dependent Cross-Talk in Cancer-Focus on Pancreatic Cancer.

Nannan L, Oudart JB, Monboisse JC, Ramont L, Brassart-Pasco S, Brassart B

Front Oncol. 2020 ;10:1456

Incremental Value of CSF Biomarkers in Clinically Diagnosed AD and Non-AD Dementia.

Oudart JB, Djerada Z, Nonnonhou V, Badr S, Bertholon LA, Dammak A, Jaidi Y, Novella JL, Pallet N, Gillery P, Mahmoudi R

Front Neurol. 2020 ;11:560

Tumor Microenvironment: Extracellular Matrix Alterations Influence Tumor Progression.

Brassart-Pasco S, Brézillon S, Brassart B, Ramont L, Oudart JB, Monboisse JC

Front Oncol. 2020 ;10:397

Molecular markers and prediction of response to immunotherapy in non-small cell lung cancer, an update.

Blons H, Garinet S, Laurent-Puig P, Oudart JB

J Thorac Dis. 2019 Jan;11(Suppl 1):S25-S36

Molecular heterogeneity assessment by NGS in non-small cell lung cancer (NSCLC) harboring EGFR mutations: Results of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France study.

Blons H, Oudart JB, Merlio JP, Hominal S, de Fraipont F, Debieuvre D, Escande F, Audigier Valette C, Bringuier PP, Moreau Fraboulet S, Ouafik L, Moro-Sibilot D, Lemoine A, Langlais A, Missy P, Morin F, Souquet PJ, Barlesi F, Cadranel J, Beau-Faller M

Ann. Oncol.. 2018 Oct;29 Suppl 8:viii39-viii40

Conformation-dependent binding of a Tetrastatin peptide to αβ integrin decreases melanoma progression through FAK/PIK/Akt pathway inhibition.

Lambert E, Fuselier E, Ramont L, Brassart B, Dukic S, Oudart JB, Dupont-Deshorgue A, Sellier C, Machado C, Dauchez M, Monboisse JC, Maquart FX, Baud S, Brassart-Pasco S

Sci Rep. 2018 Jun 29;8(1):9837